These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8585371)

  • 1. [The clinical importance of determining nitrates in the blood in patients with disseminated sclerosis].
    Karlov VA; Khokhlov AP; Riazantsev VV; Navasardiants DG; Savin AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(5):27-30. PubMed ID: 8585371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The content of lipid peroxidation products in the blood of patients with disseminated sclerosis].
    Nazarenko VG; Bessmertnaia EV; Bagriĭ EA
    Vrach Delo; 1990 Apr; (4):93-4. PubMed ID: 2275185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The intensive therapy of exacerbations in disseminated sclerosis in children].
    Evtushenko SK; Efimenko VN; Derevianko IN
    Lik Sprava; 1997; (3):131-4. PubMed ID: 9377335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parameters of antioxidant protection in multiple sclerosis].
    Krotenko NV; Alifirova VM; Ivanova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):53-6. PubMed ID: 19891349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The characteristics of the central and peripheral hemodynamics in patients with disseminated sclerosis].
    Unich PP
    Vrach Delo; 1990 Apr; (4):94-6. PubMed ID: 2275186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of a natural inhibitory factor in the pathogenesis of disseminated sclerosis].
    Dziuba AN; Frolov VM; Peresadin NA
    Lik Sprava; 1993; (2-3):93-5. PubMed ID: 8191750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nitric oxide and cardiac failure].
    Drapkina OM; Ivashkin VT
    Ter Arkh; 2005; 77(11):62-8. PubMed ID: 16404865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of glucocorticoid hormones in multiple sclerosis].
    Leonovich AL; Gitkina LS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1318-22. PubMed ID: 1015135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH].
    Wender M; Tokarz-Kupczyk E; Mularek O
    Neurol Neurochir Pol; 1988; 22(5):399-403. PubMed ID: 2854886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience with the use of cyclophosphamide in multiple sclerosis].
    Bel'man EL; Gordeev IaIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(2):201-4. PubMed ID: 842238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression].
    Wender M; Tokarz-Kupczyk E; Mularek O
    Neurol Neurochir Pol; 1989; 23(3):188-92. PubMed ID: 2561379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of NA K ATPase activity in multiple sclerosis].
    Ierusalimskiĭ AP; Kunitsin VG; Nekrasova MF; Predtechenskaia AV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):12-5. PubMed ID: 2160157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The differentiated treatment of patients with disseminated sclerosis].
    Sokolova LI
    Lik Sprava; 1998; (2):63-6. PubMed ID: 9670659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of prednisolone on the immunoglobulin content of the blood in patients with disseminated sclerosis].
    Iarosh AA; Prokopiv MM; Zhovnir IK; Kanevskaia SA
    Vrach Delo; 1990 Aug; (8):70-2. PubMed ID: 2256298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disordered lipid peroxidation and ATPase activities in patients with disseminated sclerosis].
    Turchina NS; Kravets AS; Slesarenko EV; Kanevskaia SA; Iarosh AA
    Vrach Delo; 1990 Jul; (7):69-71. PubMed ID: 2146813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glial migration inhibition test in multiple sclerosis patients and its changes during treatment with immunosuppressants].
    Kogan OG; Kanchurin AKh; Kuznetsova OV; Brusina LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(12):1798-1802. PubMed ID: 7340320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytochemical characteristics of nucleic acids in the peripheral blood lymphocytes of patients with multiple sclerosis].
    Grechukh AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(5):672-4. PubMed ID: 936868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of polyamine in the complex treatment of multiple sclerosis].
    Gusev EI; Karneev AN; Ivanokov AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(8):1126-31. PubMed ID: 4050223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total lymphoid irradiation in multiple sclerosis: blood lymphocytes and clinical course.
    Cook SD; Devereux C; Troiano R; Zito G; Hafstein M; Lavenhar M; Hernandez E; Dowling PC
    Ann Neurol; 1987 Nov; 22(5):634-8. PubMed ID: 3426169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinico-immunologic parallels in evaluating the treatment of multiple sclerosis].
    Chernigovskaia NV; Ogurtsov RP; Matveeva TS; Popov VG; Puzyreva VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):24-8. PubMed ID: 2160163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.